Nath Bio-Genes (India) Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 449.88 million compared to INR 272.12 million a year ago. Revenue was INR 449.68 million compared to INR 272.12 million a year ago. Net income was INR 14.37 million compared to net loss of INR 1,163.35 million a year ago. Basic earnings per share from continuing operations was INR 0.76 compared to basic loss per share from continuing operations of INR 61.22 a year ago.
For the full year, sales was INR 3,013.64 million compared to INR 2,783.62 million a year ago. Revenue was INR 3,013.64 million compared to INR 2,783.62 million a year ago. Net income was INR 350.11 million compared to net loss of INR 673.85 million a year ago. Basic earnings per share from continuing operations was INR 18.42 compared to basic loss per share from continuing operations of INR 35.46 a year ago.